IMC Chicago’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
11,900
-12,600
-51% -$739K ﹤0.01% 3608
2026
Q1
$936K Buy
24,500
+12,800
+109% +$405K ﹤0.01% 3351
2025
Q4
$255K Buy
+11,700
New +$243K ﹤0.01% 3893

Other funds holding ATEX

IMC Chicago's ATEX Position: Q2 2026 in Review

IMC Chicago reduced its Anterix (ATEX) stake by 90% in Q2 2026, selling an estimated $1.61M and leaving 2,929 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #5222.

IMC Chicago first reported a position in ATEX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.16M in Q1 2026. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • IMC Chicago held 2,929 shares of Anterix worth $302K as of Q2 2026.
  • IMC Chicago sold 27,434 Anterix shares in Q2 2026, an estimated $1.61M.
  • Anterix made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5222 holding.
  • IMC Chicago first reported a position in Anterix in Q4 2025 and has held it in 3 quarters since.
  • IMC Chicago's Anterix position peaked at $1.16M in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.